Literature DB >> 25344340

Management of gynecological cancers during pregnancy.

Sileny N Han1, Magali Verheecke, Tineke Vandenbroucke, Mina Mhallem Gziri, Kristel Van Calsteren, Frédéric Amant.   

Abstract

The diagnosis of a gynecological malignancy during pregnancy is rare but not uncommon. Cancer treatment during pregnancy is possible, but both maternal and fetal interests need to be respected. Different treatment plans may be justifiable and multidisciplinary treatment is advised. Clinical trials are virtually impossible, and current evidence is mainly based on small case series and expert opinion. Individualization of treatment is necessary and based on tumor type, stage, and gestational age at time of diagnosis. Termination of pregnancy is not necessary in most cases. Surgery and chemotherapy (second trimester and onwards) are possible types of treatment during pregnancy. Radiotherapy of the pelvic area is not compatible with an ongoing pregnancy. This article discusses the current recommendations for the management of gynecological malignancies (cervical, ovarian, and vulvar cancers) during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25344340     DOI: 10.1007/s11912-014-0415-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

Review 1.  Surgery in pregnancy.

Authors:  Stephen R T Evans; Babak Sarani; Parag Bhanot; Elizabeth Feldman
Journal:  Curr Probl Surg       Date:  2012-06       Impact factor: 1.909

2.  Nonsteroidal antiinflammatory drug use among women and the risk of birth defects.

Authors:  Rohini K Hernandez; Martha M Werler; Paul Romitti; Lixian Sun; Marlene Anderka
Journal:  Am J Obstet Gynecol       Date:  2011-12-01       Impact factor: 8.661

Review 3.  Non-obstetrical acute abdomen during pregnancy.

Authors:  Goran Augustin; Mate Majerovic
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-09-18       Impact factor: 2.435

4.  Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel.

Authors:  J G C van Hasselt; K van Calsteren; L Heyns; S Han; M Mhallem Gziri; J H M Schellens; J H Beijnen; A D R Huitema; F Amant
Journal:  Ann Oncol       Date:  2014-04-08       Impact factor: 32.976

5.  Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.

Authors:  Frédéric Amant; Kristel Van Calsteren; Michael J Halaska; Mina Mhallem Gziri; Wei Hui; Lieven Lagae; Michèl A Willemsen; Livia Kapusta; Ben Van Calster; Heidi Wouters; Liesbeth Heyns; Sileny N Han; Viktor Tomek; Luc Mertens; Petronella B Ottevanger
Journal:  Lancet Oncol       Date:  2012-02-10       Impact factor: 41.316

6.  Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.

Authors:  Frédéric Amant; Gunter von Minckwitz; Sileny N Han; Marijke Bontenbal; Alistair E Ring; Jerzy Giermek; Hans Wildiers; Tanja Fehm; Sabine C Linn; Bettina Schlehe; Patrick Neven; Pieter J Westenend; Volkmar Müller; Kristel Van Calsteren; Brigitte Rack; Valentina Nekljudova; Nadia Harbeck; Michael Untch; Petronella O Witteveen; Kathrin Schwedler; Christoph Thomssen; Ben Van Calster; Sibylle Loibl
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

Review 7.  Emerging therapeutic options for breast cancer chemotherapy during pregnancy.

Authors:  O Mir; P Berveiller; S Ropert; F Goffinet; G Pons; J-M Treluyer; F Goldwasser
Journal:  Ann Oncol       Date:  2007-10-05       Impact factor: 32.976

8.  Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes.

Authors:  Kristel Van Calsteren; Liesbeth Heyns; Frank De Smet; Liesbet Van Eycken; Mina Mhallem Gziri; Willemijn Van Gemert; Michael Halaska; Ignace Vergote; Nelleke Ottevanger; Frédéric Amant
Journal:  J Clin Oncol       Date:  2009-10-19       Impact factor: 44.544

9.  Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.

Authors:  Hanne Stensheim; Bjørn Møller; Tini van Dijk; Sophie D Fosså
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

10.  Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review.

Authors:  Sileny N Han; Anouk Lotgerink; Mina Mhallem Gziri; Kristel Van Calsteren; Myriam Hanssens; Frédéric Amant
Journal:  BMC Med       Date:  2012-08-08       Impact factor: 8.775

View more
  12 in total

1.  Comparison of Adnexal Mass in Women Undergoing Mass Excision During the Antepartum Period and Cesarean Section.

Authors:  Nafiseh Saghafi; Zohreh Yousefi Roodsary; Sima Kadkhodaeian; Maliheh Hasanzadeh Mofrad; Elham Hosseini Farahabadi; Mohammadreza Hoseinyfarahabady
Journal:  Oman Med J       Date:  2016-05

2.  Extremely large epithelial ovarian cancer associated with pregnancy: A case report.

Authors:  Viktoria Husz; Dorottya Bus; Gyorgy Vajda
Journal:  Mol Clin Oncol       Date:  2017-11-15

Review 3.  Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.

Authors:  Angela Collarino; Valentina Fuoco; Giorgia Garganese; Lenka M Pereira Arias-Bouda; Germano Perotti; Gianpiero Manca; Sergi Vidal-Sicart; Francesco Giammarile; Lioe-Fee de Geus-Oei; Giovanni Scambia; Alessandro Giordano; Renato A Valdés-Olmos; Marco Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-02       Impact factor: 9.236

Review 4.  Management of ovarian cysts and cancer in pregnancy.

Authors:  J de Haan; M Verheecke; F Amant
Journal:  Facts Views Vis Obgyn       Date:  2015

Review 5.  Gynaecological cancers coexisting with pregnancy - a literature review.

Authors:  Anna Skrzypczyk-Ostaszewicz; Maryna Rubach
Journal:  Contemp Oncol (Pozn)       Date:  2016-08-04

6.  Teenage pregnancy complicated by primary invasive ovarian cancer: association for oncologic outcome.

Authors:  Erin A Blake; Madushka Y De Zoysa; Elise B Morocco; Samantha B Kaiser; Michiko Kodama; Brendan H Grubbs; Koji Matsuo
Journal:  J Gynecol Oncol       Date:  2018-06-27       Impact factor: 4.401

7.  Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach.

Authors:  Ana Isabel Bueno Moral; Jose Carlos Vilches Jiménez; Adriana Serrano Olave; María Pilar Espejo Reina; María Estrella Valdivia de Dios; Jesús S Jiménez López
Journal:  Medicina (Kaunas)       Date:  2021-04-28       Impact factor: 2.430

8.  Vulval cancer in pregnancy: Two case reports.

Authors:  Ellen Gaunt; Rachel Pounds; Jason Yap
Journal:  Case Rep Womens Health       Date:  2021-12-11

Review 9.  Gynecologic Malignancies in Pregnancy: Balancing Fetal Risks With Oncologic Safety.

Authors:  Christina N Cordeiro; Mary L Gemignani
Journal:  Obstet Gynecol Surv       Date:  2017-03       Impact factor: 2.347

10.  A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.

Authors:  László Mangel; Krisztina Bíró; István Battyáni; Péter Göcze; Tamás Tornóczky; Endre Kálmán
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.